|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.970 CAD | -2.24% |
|
0.00% | -26.40% |
| 19/03 | Vitalhub Corp., Q4 2025 Earnings Call, Mar 19, 2026 | |
| 19/03 | Earnings Flash (VHI.TO) VitalHub Reported Q4 Total Revenue $31.4M; Net Income of $4.067M | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.44Cr | 3.99Cr | 5.25Cr | 6.85Cr | 11Cr | |||||
Other Revenues, Total | 3L | 92.86T | 28.47T | 1L | 1L | |||||
Total Revenues | 2.47Cr | 4Cr | 5.25Cr | 6.86Cr | 11Cr | |||||
Cost of Goods Sold, Total | 52.37L | 70.32L | 96.98L | 1.31Cr | 2.14Cr | |||||
Gross Profit | 1.94Cr | 3.29Cr | 4.28Cr | 5.55Cr | 8.76Cr | |||||
Selling General & Admin Expenses, Total | 86.94L | 1.28Cr | 1.76Cr | 2.22Cr | 3.27Cr | |||||
Stock-Based Compensation (IS) | 17.17L | 11.4L | 11.56L | 23.44L | 26.48L | |||||
R&D Expenses | 60.46L | 1.04Cr | 1.22Cr | 1.52Cr | 2.9Cr | |||||
Depreciation & Amortization - (IS) | 4L | 6L | 7L | 8L | 12.72L | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 22.41L | 32.8L | 42.59L | 51.49L | 98.1L | |||||
Other Operating Expenses, Total | 1.91Cr | 2.83Cr | 3.6Cr | 4.58Cr | 7.54Cr | |||||
Operating Income | 3L | 46.63L | 68.58L | 97.42L | 1.22Cr | |||||
Interest Expense, Total | -82.43T | -70.34T | -71.98T | -43T | -70.35T | |||||
Interest And Investment Income | 29.55T | - | 5L | 19.51L | 24.18L | |||||
Net Interest Expenses | -52.88T | -70.34T | 4L | 19.08L | 23.48L | |||||
Currency Exchange Gains (Loss) | -1L | -2L | 3L | -2L | 7L | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 1L | 44.42L | 75.73L | 1.14Cr | 1.52Cr | |||||
Merger & Related Restructuring Charges | -17.16L | -24.39L | -15.35L | -52.13L | -88.11L | |||||
Gain (Loss) On Sale Of Assets | -1.59T | -1.06T | 2.1T | 141 | -5.88T | |||||
Other Unusual Items | - | -7L | -7L | -3L | -5L | |||||
EBT, Incl. Unusual Items | -16.14L | 13.07L | 53.28L | 58.96L | 59.01L | |||||
Income Tax Expense | 3L | 92.08T | 8L | 28.97L | -2L | |||||
Earnings From Continuing Operations | -19.47L | 12.15L | 45.49L | 29.99L | 61.11L | |||||
Net Income to Company | -19.47L | 12.15L | 45.49L | 29.99L | 61.11L | |||||
Net Income - (IS) | -19.47L | 12.15L | 45.49L | 29.99L | 61.11L | |||||
Net Income to Common Incl Extra Items | -19.47L | 12.15L | 45.49L | 29.99L | 61.11L | |||||
Net Income to Common Excl. Extra Items | -19.47L | 12.15L | 45.49L | 29.99L | 61.11L | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.05 | 0.03 | 0.1 | 0.06 | 0.1 | |||||
Basic EPS - Continuing Operations | -0.05 | 0.03 | 0.1 | 0.06 | 0.1 | |||||
Basic Weighted Average Shares Outstanding | 3.64Cr | 4.15Cr | 4.36Cr | 4.92Cr | 5.85Cr | |||||
Net EPS - Diluted | -0.05 | 0.03 | 0.1 | 0.06 | 0.1 | |||||
Diluted EPS - Continuing Operations | -0.05 | 0.03 | 0.1 | 0.06 | 0.1 | |||||
Diluted Weighted Average Shares Outstanding | 3.64Cr | 4.26Cr | 4.66Cr | 5.09Cr | 6.03Cr | |||||
Normalized Basic EPS | 0 | 0.07 | 0.11 | 0.15 | 0.16 | |||||
Normalized Diluted EPS | 0 | 0.07 | 0.1 | 0.14 | 0.16 | |||||
Supplemental Items | ||||||||||
EBITDA | 20.29L | 72.44L | 1.03Cr | 1.4Cr | 2.05Cr | |||||
EBITA | 18.66L | 69.94L | 99.83L | 1.36Cr | 1.98Cr | |||||
EBIT | 3L | 46.63L | 68.58L | 97.42L | 1.22Cr | |||||
EBITDAR | 21.89L | 75.49L | 1.08Cr | 1.47Cr | 2.12Cr | |||||
Total Revenues (As Reported) | 2.47Cr | 4Cr | 5.25Cr | 6.86Cr | 11Cr | |||||
Effective Tax Rate - (Ratio) | -20.64 | 7.05 | 14.61 | 49.13 | -3.55 | |||||
Total Current Taxes | 2L | 3L | 10L | 40.43L | 29.54L | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | 2L | -2L | -2L | -11.46L | -31.63L | |||||
Normalized Net Income | 64.98T | 27.76L | 47.33L | 71.5L | 94.87L | |||||
Interest on Long-Term Debt | 82.43T | 29.43T | 71.98T | 43T | 70.35T | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 2L | 4L | 5L | 5L | 8L | |||||
Selling and Marketing Expenses | 36.14L | 42.75L | 58.83L | 67.66L | 1.03Cr | |||||
General and Administrative Expenses | 50.79L | 85.56L | 1.18Cr | 1.55Cr | 2.25Cr | |||||
Research And Development Expense From Footnotes | 67.15L | 1.14Cr | 1.33Cr | 1.65Cr | 3.11Cr | |||||
Net Rental Expense, Total | 2L | 3L | 5L | 7L | 7L | |||||
Imputed Operating Lease Interest Expense | 1L | 2L | 4L | 4L | 2L | |||||
Imputed Operating Lease Depreciation | 41.38T | 99.95T | 99.15T | 3L | 4L | |||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 17.17L | 11.4L | 11.56L | 23.44L | 26.48L | |||||
Total Stock-Based Compensation | 17.17L | 11.4L | 11.56L | 23.44L | 26.48L |
- Stock Market
- Equities
- VHI Stock
- Financials Vitalhub Corp.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















